semaglutide asa guidelines Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk 2026 Dyslipidemia Guidelines: Key Updates

AWARD-6 is a randomized, open, parallel-grouped, multicenter, phase 3, non-inferiority study comparing the safety and efficacy of weekly DUL and daily LIR in patients with uncontrolled T2DM treated with metformin

Ozempic Ozempic helps people lose weight while managing blood sugar levels, making it valuable for patients with both obesity and type 2 diabetes

If you are considering longevity peptide therapy and want a protocol built on documented compatibility rather than internet speculation, the evaluation at Perfect B is the starting point

Understanding patient variability at this scale could not only enable precision medicine, but also refine how we approach preclinical studies, model choice and biomarker development

If youre ready to prioritize your health and are seeking effective, metabolically directed treatments, contact us online or call (732) 268-7663 for a consultation with Dr